The prognosis for patients diagnosed with scleroderma – an autoimmune disease characterized by fibrosis of the skin – is not typically a rosy one. With limited treatment options available, those

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field